<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4930207</article-id><article-id pub-id-type="pmid">27367859</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0158579</article-id><article-id pub-id-type="publisher-id">PONE-D-15-48711</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Luminescent Proteins</subject><subj-group><subject>Aequorin</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Physics</subject><subj-group><subject>Electromagnetic Radiation</subject><subj-group><subject>Luminescence</subject><subj-group><subject>Bioluminescence</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>In Vivo Imaging</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>DNA construction</subject><subj-group><subject>Plasmid Construction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>DNA construction</subject><subj-group><subject>Plasmid Construction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Materials Science</subject><subj-group><subject>Material Properties</subject><subj-group><subject>Emission Spectra</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Physics</subject><subj-group><subject>Condensed Matter Physics</subject><subj-group><subject>Solid State Physics</subject><subj-group><subject>Crystallography</subject><subj-group><subject>Crystal Structure</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Compounds</subject><subj-group><subject>Organic Compounds</subject><subj-group><subject>Amino Acids</subject><subj-group><subject>Aromatic Amino Acids</subject><subj-group><subject>Tyrosine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic Chemistry</subject><subj-group><subject>Organic Compounds</subject><subj-group><subject>Amino Acids</subject><subj-group><subject>Aromatic Amino Acids</subject><subj-group><subject>Tyrosine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Amino Acids</subject><subj-group><subject>Aromatic Amino Acids</subject><subj-group><subject>Tyrosine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Compounds</subject><subj-group><subject>Organic Compounds</subject><subj-group><subject>Amino Acids</subject><subj-group><subject>Hydroxyl Amino Acids</subject><subj-group><subject>Tyrosine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic Chemistry</subject><subj-group><subject>Organic Compounds</subject><subj-group><subject>Amino Acids</subject><subj-group><subject>Hydroxyl Amino Acids</subject><subj-group><subject>Tyrosine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Amino Acids</subject><subj-group><subject>Hydroxyl Amino Acids</subject><subj-group><subject>Tyrosine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Red-Shifted Aequorin Variants Incorporating Non-Canonical Amino Acids: Applications in <italic>In Vivo</italic> Imaging</article-title><alt-title alt-title-type="running-head">Aequorin in <italic>In Vivo</italic> Imaging</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Grinstead</surname><given-names>Kristen M.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rowe</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ensor</surname><given-names>Charles M.</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Joel</surname><given-names>Smita</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Daftarian</surname><given-names>Pirouz</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dikici</surname><given-names>Emre</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zingg</surname><given-names>Jean-Marc</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Daunert</surname><given-names>Sylvia</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Biochemistry and Molecular Biology, R. Bunn Gautier Bldg., 1011 NW 15th Street, Miller School of Medicine, University of Miami, Miami, FL, 33136, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Chemistry, 1610 Campus Drive East, Valparaiso University, Valparaiso, IN, 46385, United States of America</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, 40536, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Jones</surname><given-names>D. Dafydd</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Cardiff University, UNITED KINGDOM</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: KG LR PD SD. Performed the experiments: KG PD. Analyzed the data: KG CE ED. Contributed reagents/materials/analysis tools: KG LR CE ED. Wrote the paper: KG LR CE SJ ED PD JZ SD.</p></fn><corresp id="cor001">* E-mail: <email>SDaunert@med.miami.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>1</day><month>7</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>7</issue><elocation-id>e0158579</elocation-id><history><date date-type="received"><day>6</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>17</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Grinstead et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Grinstead et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0158579.pdf"/><abstract><p>The increased importance of <italic>in vivo</italic> diagnostics has posed new demands for imaging technologies. In that regard, there is a need for imaging molecules capable of expanding the applications of current state-of-the-art imaging <italic>in vivo</italic> diagnostics. To that end, there is a desire for new reporter molecules capable of providing strong signals, are non-toxic, and can be tailored to diagnose or monitor the progression of a number of diseases. Aequorin is a non-toxic photoprotein that can be used as a sensitive marker for bioluminescence <italic>in vivo</italic> imaging. The sensitivity of aequorin is due to the fact that bioluminescence is a rare phenomenon in nature and, therefore, it does not suffer from autofluorescence, which contributes to background emission. Emission of bioluminescence in the blue-region of the spectrum by aequorin only occurs when calcium, and its luciferin coelenterazine, are bound to the protein and trigger a biochemical reaction that results in light generation. It is this reaction that endows aequorin with unique characteristics, making it ideally suited for a number of applications in bioanalysis and imaging. Herein we report the site-specific incorporation of non-canonical or non-natural amino acids and several coelenterazine analogues, resulting in a catalog of 72 cysteine-free, aequorin variants which expand the potential applications of these photoproteins by providing several red-shifted mutants better suited to use <italic>in vivo</italic>. <italic>In vivo</italic> studies in mouse models using the transparent tissue of the eye confirmed the activity of the aequorin variants incorporating L-4-iodophehylalanine and L-4-methoxyphenylalanine after injection into the eye and topical addition of coelenterazine. The signal also remained localized within the eye. This is the first time that aequorin variants incorporating non-canonical amino acids have shown to be active <italic>in vivo</italic> and useful as reporters in bioluminescence imaging.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>7R01GM047915</award-id><principal-award-recipient><name><surname>Daunert</surname><given-names>Sylvia</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution>Lucille P. Markey Chair</institution></funding-source><principal-award-recipient><name><surname>Daunert</surname><given-names>Sylvia</given-names></name></principal-award-recipient></award-group><funding-statement>This study was funded by the National Institutes of Health, grant number 7R01GM047915, and by the Lucille P. Markey Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="1"/><page-count count="17"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Imaging is a critical component of medical diagnostics and biomedical research. X-Ray computed tomography, ultrasonography, magnetic resonance imaging (MRI), and positron emission tomography imaging (PET), and optical methods based on fluorescence or bioluminescence are used as stand-alone or in-tandem in diagnostic imaging to provide information on morphological, anatomical, or organ function. Despite their wide use, the majority of these methods do not have the ability to monitor specific molecular events linked to disease states and provide a complete picture of a biochemical process. <italic>In vivo</italic> imaging systems (IVIS) [<xref rid="pone.0158579.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0158579.ref004" ref-type="bibr">4</xref>] is currently the state-of-the-art instrumentation used in molecular imaging to investigate biological processes in whole animal bioluminescence imaging (BLI) employing reporter technologies. IVIS has a fast image acquisition time (from seconds to a few minutes) and can be used to image several animals at once, providing a high throughput cost-effective alternative.</p><p>&#x0201c;Living light&#x0201d; or bioluminescence, is a naturally occurring phenomenon where light is generated by living organisms. Bioluminescence has several advantages over fluorescence, most notably the high sensitivity shown by the subattomole detection limits <italic>in vitro</italic>, and low background caused by the lack of inherent bioluminescence in most tissues [<xref rid="pone.0158579.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0158579.ref008" ref-type="bibr">8</xref>]. Furthermore, bioluminescence does not require external illumination, making it suitable for light sensitive organs and tissues such as the retina.</p><p>Bioluminescent studies have frequently been conducted using the intracellular expression of proteins such as firefly luciferase (FLuc) and <italic>Renilla</italic> luciferase (RLuc) [<xref rid="pone.0158579.ref009" ref-type="bibr">9</xref>&#x02013;<xref rid="pone.0158579.ref021" ref-type="bibr">21</xref>]. Though these proteins have the benefits of bioluminescence and have been used for <italic>in vivo</italic> cell tracking and gene expression, they require the incorporation of foreign DNA or the transplant of transgenic tissue [<xref rid="pone.0158579.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0158579.ref023" ref-type="bibr">23</xref>]. To overcome these drawbacks, we propose the direct administration of engineered red-shifted emission variants of the photoprotein aequorin, a protein employed previously in deep tissue calcium measurements [<xref rid="pone.0158579.ref024" ref-type="bibr">24</xref>].</p><p>Aequorin is a 22 kDa non-toxic photoprotein originally isolated from the bioluminescent jellyfish <italic>Aequorea victoria</italic> and employed initially for <italic>in vivo</italic> calcium detection [<xref rid="pone.0158579.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0158579.ref026" ref-type="bibr">26</xref>]. In addition, aequorin has found numerous applications in cell trafficking [<xref rid="pone.0158579.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0158579.ref028" ref-type="bibr">28</xref>], biosensing [<xref rid="pone.0158579.ref029" ref-type="bibr">29</xref>&#x02013;<xref rid="pone.0158579.ref032" ref-type="bibr">32</xref>], and in bioluminescent competitive [<xref rid="pone.0158579.ref030" ref-type="bibr">30</xref>] and immunoassays [<xref rid="pone.0158579.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0158579.ref041" ref-type="bibr">41</xref>]. Aequorin uses the conversion of the incorporated luciferin coelenterazine to coelenteramide to emit a flash of light at 472 nm. The coelenterazine is bracketed in the hydrophobic pocket by H-bonds with three triads: Tyr184-His169-Trp173, Tyr192-His58-Trp108, and Tyr82-His16-Trp86 [<xref rid="pone.0158579.ref042" ref-type="bibr">42</xref>&#x02013;<xref rid="pone.0158579.ref044" ref-type="bibr">44</xref>] (<xref ref-type="fig" rid="pone.0158579.g001">Fig 1</xref>). The addition of calcium causes a change in the conformation of the protein, triggering the bioluminescence reaction. The availability of different synthetic coelenterazine analogs with a variety of emission maxima and half-lives, allows for the tuning of emitted light [<xref rid="pone.0158579.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0158579.ref046" ref-type="bibr">46</xref>]. Since wild-type aequorin emits in the blue region of the visible spectrum, and since the emitted light at that particular wavelength is more easily absorbed and scattered by tissue, the availability of red-shifted aequorin mutants is important for further expanding its role <italic>in vivo</italic>.</p><fig id="pone.0158579.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0158579.g001</object-id><label>Fig 1</label><caption><title>Structures of wild-type aequorin and the non-natural amino acid analogs employed for site-selective incorporation into the protein.</title><p>(A) Crystal structure of aequorin with the location of the Tyr82-His16-Trp86. The substituted tyrosine is at position 82 and the substituted tryptophan is at position 86. (B) Chemical structure of non-natural amino acids: L-4-aminophenylalanine, (C) L-4-bromophenylalanine, (D) L-4-iodophenylalanine, (E) L-4 methoxyphenylalanine (PDB ID: 1EJ3). Reprinted from [<xref rid="pone.0158579.ref047" ref-type="bibr">47</xref>]under a CC BY license, with permission from <italic>Open Access Dissertations</italic>, original copyright 2015.</p></caption><graphic xlink:href="pone.0158579.g001"/></fig><p>In addition to synthetic coelenterazine, random and site-directed mutations have been used by us and others to create a variety of aequorin analogs with different wavelengths of emission and half-lives [<xref rid="pone.0158579.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0158579.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0158579.ref048" ref-type="bibr">48</xref>&#x02013;<xref rid="pone.0158579.ref054" ref-type="bibr">54</xref>]. Although aequorin variants with unique spectral characteristics using canonical amino acids have been created, the range of emission properties can be further tailored by strategic incorporation of non-natural amino acids [<xref rid="pone.0158579.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0158579.ref053" ref-type="bibr">53</xref>].</p><p>Previous studies have shown that mutations in the protein sequence involving the Tyr82-His16-Trp86 triads using canonical amino acids have a great effect on the spectral characteristics of aequorin while maintaining its bioluminescent activity, most notably a red-shift in the emission wavelength. This led to the selection of the tyrosine at position 82 and tryptophan at position 86 for replacement in a cysteine-free aequorin variant (hereafter &#x0201c;aequorin&#x0201c;), to minimize the absorption of the signal by tissue during <italic>in vivo</italic> studies, such as in calcium imaging and in the previously mentioned deep tissue studies [<xref rid="pone.0158579.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0158579.ref055" ref-type="bibr">55</xref>]. In this study, the tryptophan residue at position 86 was replaced with four different non-natural amino acids L-4-aminophenylalanine (AminoPhe), L-4-bromophenylalanine (BromoPhe), L-4-iodophenylalanine (IodoPhe), and L-4-methoxyphenylalanine (MethoxyPhe). The position was also substituted simultaneously with the tyrosine at position 82. The variants were then complexed with native coelenterazine and eight synthetic coelenterazines <italic>cp</italic>, <italic>f</italic>, <italic>fcp</italic>, <italic>h</italic>, <italic>hcp</italic>, <italic>i</italic>, <italic>ip</italic>, and <italic>n</italic> (<xref ref-type="fig" rid="pone.0158579.g002">Fig 2</xref>).</p><fig id="pone.0158579.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0158579.g002</object-id><label>Fig 2</label><caption><title>Structures of synthetic coelenterazines.</title><p>Reprinted from [<xref rid="pone.0158579.ref047" ref-type="bibr">47</xref>] under a CC BY license, with permission from <italic>Open Access Dissertations</italic>, original copyright 2015.</p></caption><graphic xlink:href="pone.0158579.g002"/></fig><p>To test the applicability of these red-shifted aequorin variants for <italic>in vivo</italic> imaging the variant with the greatest red-shifted wavelength and the variant with the longest half-life were each injected introsomally into the eye of a 6&#x02013;8 week old ICR (CD1) outbred female mouse. The bioluminescence was then triggered by topical addition of coelenterazine and the emission of light detected with a IVIS instrument. Though aequorin has been part of imaging tissues as difficult to access as the deep brain, [<xref rid="pone.0158579.ref056" ref-type="bibr">56</xref>], the eye was chosen for our initial visualization studies because of its characteristics of optical transparency, simple anatomy, well-defined structure, and easy accessibility.</p></sec><sec id="sec002"><title>Results and Discussion</title><p>To circumvent the limitations of current luminescent proteins in imaging and expand their use <italic>in vivo</italic>, we have prepared a catalog of mutants of the tunable photoprotein aequorin [<xref rid="pone.0158579.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0158579.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0158579.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0158579.ref057" ref-type="bibr">57</xref>]. We prepared these variants by site-specifically incorporating non-natural amino acids into selected sites of the hydrophobic pocket of aequorin using Amber Suppression [<xref rid="pone.0158579.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0158579.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0158579.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0158579.ref059" ref-type="bibr">59</xref>]. Previous work in our group employing Amber Suppression replaced a tyrosine residue at position 82 by introducing a TAG codon to create functional non-natural variants of aequorin with red-shifted wavelengths of emission and longer bioluminescence half-lives [<xref rid="pone.0158579.ref046" ref-type="bibr">46</xref>]. In the present study, our group individually incorporated four different non-natural amino acids, specifically, L-4-aminophenylalanine (AminoPhe), L-4-bromophenylalanine (BromoPhe), L-4-iodophenylalanine (IodoPhe), and L-4-methoxyphenylalanine (MethoxyPhe), into aequorin at position 86 alone and 82 and 86 together (<xref ref-type="fig" rid="pone.0158579.g001">Fig 1</xref>). These non-natural amino acid residues were selected for their hydrophobicity, aromaticity, and their size similarity to tyrosine and tryptophan [<xref rid="pone.0158579.ref042" ref-type="bibr">42</xref>&#x02013;<xref rid="pone.0158579.ref044" ref-type="bibr">44</xref>]. By complexing them with native coelenterazine and eight synthetic coelenterazine analogs, this work resulted in 72 new bioluminescent aequorin variants; several of these variants had red-shifted wavelengths of emission, and both shorter and longer bioluminescence half-lives were observed as compared to those of native aequorin.</p><p>Two plasmid systems were developed to express the aequorin variants. The first system incorporated the non-natural amino acids into position 86 using a pBAD/HisA vector by using well-established molecular biology protocols [<xref rid="pone.0158579.ref060" ref-type="bibr">60</xref>] that was co-transformed with pDULE vectors engineered for each non-natural amino acid procured from the Schultz group [<xref rid="pone.0158579.ref061" ref-type="bibr">61</xref>]. This resulted in a system in which the expression of aequorin is tightly regulated by the <italic>ara</italic>BAD promoter and protein expression is induced by the addition of arabinose to the culture medium. The culture was then spun down and aequorin isolated from the supernatant by acid precipitation. Low-level expression of the L-4-aminophenylalanine aequorin prompted the generation of a second system in which the aequorin gene with a TAG codon at position 86 was inserted into a pET30Xa/LIC plasmid. This construct produced a good yield of the 86 variant aequorin and was used in all subsequent experiments (<xref ref-type="supplementary-material" rid="pone.0158579.s001">S1 Fig</xref>). The pETXa/LIC also included a His6x tag to aid in purification.</p><p>The protein variants were prepared by supplementing the culture media containing the appropriate plasmids with the selected non-natural amino acid and expression was induced with IPTG. The cells were lysed, and the protein variants were isolated and purified using affinity chromatography. Incorporation of the non-natural amino acids was verified by mass spectrometry (<xref ref-type="supplementary-material" rid="pone.0158579.s003">S1 Table</xref>, <xref ref-type="supplementary-material" rid="pone.0158579.s009">S7</xref>&#x02013;<xref ref-type="supplementary-material" rid="pone.0158579.s013">S11</xref> Tables) and the resulting variants were complexed with one of nine different coelenterazine analogs: <italic>native</italic>, <italic>cp</italic>, <italic>f</italic>, <italic>fcp</italic>, <italic>h</italic>, <italic>hcp</italic>, <italic>i</italic>, <italic>ip</italic>, or <italic>n</italic>. The resulting aequorin variants were characterized for specific activity, wavelength emission maximum, and bioluminescence emission half-life (<xref ref-type="supplementary-material" rid="pone.0158579.s004">S2</xref>&#x02013;<xref ref-type="supplementary-material" rid="pone.0158579.s006">S4</xref> Tables). Though not all mutants displayed a marked red-shift and also displayed the loss in specific activity associated with synthetic coelenterazine analogs, several mutant aequorin and synthetic coelenterazine complexes showed suitable emission characteristics.</p><p>The data in <xref rid="pone.0158579.t001" ref-type="table">Table 1</xref> shows the change in the wavelength maximum emission spectra and bioluminescence emission half-lives for selected variants as well as wild-type aequorin. The aequorin variants with single substitutions at position 86 showed longer bioluminescence emission half-lives than those found in our previous study with an aequorin containing a single non-natural incorporation at position 82. Further, the double non-natural incorporation produces variants with a marked red-shifted wavelength of bioluminescence emission [<xref rid="pone.0158579.ref046" ref-type="bibr">46</xref>]. Most significantly, aequorin with L-4-methoxyphenylalanine at positions 82 and 86 complexed with coelenterazine <italic>i</italic> emits maximal bioluminescence at 526 nm, which is the largest red-shift of wavelength of any aequorin variant reported thus far and 11 nm longer than the previous most red-shifted aequorin, namely, L-4-methoxyphenylalanine at position 82 [<xref rid="pone.0158579.ref046" ref-type="bibr">46</xref>]. <xref ref-type="fig" rid="pone.0158579.g003">Fig 3</xref> shows the interactions of the tryptophan residue at position 86 with the coelenterazine molecule. By mutating the Trp86, the stability of the phenol ring moiety associated with the Tyr82-His16-Trp86 triad is affected by the change in the H-bond network. In examining the binding interactions of the amino acids in the binding pocket with the newly prepared variant aequorin with L-4-aminophenylalanine and L-4- methoxyphenylalanine, it is evident that these non-natural amino acids, which have an amino group and methoxy group, respectively, are capable of maintaining a polar interaction with coelenterazine, while L-4-bromophenylalanine and L-4-iodophenylanine are not. We postulate that the loss of the H-bonds that stabilize the luciferin could explain the red-shifted emission wavelengths of the halogenated aequorin variants L-4-bromophenylalanine and L-4-iodophenylanine. Also, the presence of iodine in a molecule can increase the transition probability of an electron in an excited singlet state to an excited triplet state, creating a shift in the emission spectra as well as the elongation of the half-life [<xref rid="pone.0158579.ref062" ref-type="bibr">62</xref>].</p><table-wrap id="pone.0158579.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0158579.t001</object-id><label>Table 1</label><caption><title>Emission characteristics of selected aequorin variants.</title></caption><alternatives><graphic id="pone.0158579.t001g" xlink:href="pone.0158579.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Aequorin and CTZ</th><th align="justify" rowspan="1" colspan="1">Wavelength (nm)</th><th align="justify" rowspan="1" colspan="1">Half-life (s)</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">Wild-type Aequorin and <italic>Native</italic></td><td align="justify" rowspan="1" colspan="1">472</td><td align="char" char="." rowspan="1" colspan="1">0.5</td></tr><tr><td align="justify" rowspan="1" colspan="1">IodoPhe 86 <italic>Native</italic></td><td align="justify" rowspan="1" colspan="1">499</td><td align="char" char="." rowspan="1" colspan="1">14.3</td></tr><tr><td align="justify" rowspan="1" colspan="1">IodoPhe 86 <italic>i</italic></td><td align="justify" rowspan="1" colspan="1">508</td><td align="char" char="." rowspan="1" colspan="1">38.01</td></tr><tr><td align="justify" rowspan="1" colspan="1">AminoPhe 82&#x00026;86 <italic>Native</italic></td><td align="justify" rowspan="1" colspan="1">496</td><td align="char" char="." rowspan="1" colspan="1">3.57</td></tr><tr><td align="justify" rowspan="1" colspan="1">AminoPhe 82&#x00026;86 <italic>i</italic></td><td align="justify" rowspan="1" colspan="1">515</td><td align="char" char="." rowspan="1" colspan="1">58.68</td></tr><tr><td align="justify" rowspan="1" colspan="1">BromoPhe 82&#x00026;86 <italic>Native</italic></td><td align="justify" rowspan="1" colspan="1">500</td><td align="char" char="." rowspan="1" colspan="1">3.21</td></tr><tr><td align="justify" rowspan="1" colspan="1">BromoPhe 82&#x00026;86 <italic>i</italic></td><td align="justify" rowspan="1" colspan="1">514</td><td align="char" char="." rowspan="1" colspan="1">55.62</td></tr><tr><td align="justify" rowspan="1" colspan="1">IodoPhe 82&#x00026;86 <italic>Native</italic></td><td align="justify" rowspan="1" colspan="1">500</td><td align="char" char="." rowspan="1" colspan="1">4.19</td></tr><tr><td align="justify" rowspan="1" colspan="1">IodoPhe 82&#x00026;86 <italic>i</italic></td><td align="justify" rowspan="1" colspan="1">508</td><td align="char" char="." rowspan="1" colspan="1">64.74</td></tr><tr><td align="justify" rowspan="1" colspan="1">MethoxyPhe 82&#x00026;86 <italic>Native</italic></td><td align="justify" rowspan="1" colspan="1">513</td><td align="char" char="." rowspan="1" colspan="1">3.53</td></tr><tr><td align="justify" rowspan="1" colspan="1">MethoxyPhe 82&#x00026;86 <italic>i</italic></td><td align="justify" rowspan="1" colspan="1">526</td><td align="char" char="." rowspan="1" colspan="1">48.73</td></tr></tbody></table></alternatives></table-wrap><fig id="pone.0158579.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0158579.g003</object-id><label>Fig 3</label><caption><title>Native coelenterazine in the binding pocket of aequorin.</title><p>The grey dashed lines represent the Van der Waal surface of the ligand. Green dashed lines with an arrowhead represent an H-bond going from donor to recipient. The structure is based on aequorin&#x02019;s crystal structure [<xref rid="pone.0158579.ref043" ref-type="bibr">43</xref>](PDB ID: 1EJ3). Reprinted from [<xref rid="pone.0158579.ref047" ref-type="bibr">47</xref>] under a CC BY license, with permission from <italic>Open Access Dissertations</italic>, original copyright 2015.</p></caption><graphic xlink:href="pone.0158579.g003"/></fig><p>While all novel non-natural amino acid-modified aequorin variants show an increase in the half-lives of the bioluminescence emission, the most notable half-life changes are associated with the variants containing coelenterazine <italic>i</italic>. These variants display the longest bioluminescence decay half-lives with an average of approximately 1 minute, while the half-life of aequorin with native coelenterazine is approximately a half second (<xref rid="pone.0158579.t001" ref-type="table">Table 1</xref>). Notably, the aequorin variant with a double substitution of L-4-iodophenylalanine at positions 82 and 86 paired with coelenterazine <italic>i</italic> has the longest bioluminescence half-life emission time reported as well at approximately 60 s, compared to our own previously reported 14 s with a single L-4-methoxyphenylalanine at position 82 paired with coelenterazine <italic>i</italic> (<xref ref-type="fig" rid="pone.0158579.g004">Fig 4</xref>) [<xref rid="pone.0158579.ref046" ref-type="bibr">46</xref>].</p><fig id="pone.0158579.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0158579.g004</object-id><label>Fig 4</label><caption><title>Emission wavelengths and bioluminescence half-lives of selected aequorin variants.</title><p>(A) Bioluminescence emission spectra of aequorin with L-4-aminophenylalanine at position 86 with coelenterazine <italic>cp</italic> (red), aequorin with native coelenterazine (black), and L-4-methoxyphenylalanine at position 82 and 86 with coelenterazine <italic>i</italic> (green), illustrating the range of emission wavelengths in this study. (B) Half-life bioluminescence decay of aequorin with native coelenterazine (black), L-4-methoxyphenylalanine with coelenterazine <italic>n</italic> (orange), and L-4-iodophenylalanine with coelenterazine <italic>i</italic> (blue), illustrating the range of emission half-lives in this study. Reprinted from [<xref rid="pone.0158579.ref047" ref-type="bibr">47</xref>] under a CC BY license, with permission from <italic>Open Access Dissertations</italic>, original copyright 2015.</p></caption><graphic xlink:href="pone.0158579.g004"/></fig><p>The increased probability of the transition of the excited electron from singlet state to triplet state due to the heavy atom can explain the differences in half-lives of the coelenterazines that have iodine compared to the ones that do not possess a heavy atom [<xref rid="pone.0158579.ref062" ref-type="bibr">62</xref>]. This trend is also present in the modified aequorins with a L-4-bromophenylalanine substitution, though to a lesser extent. Interestingly, in our previous work, the single substitution of Tyr82 did not display as great an increase in the half-life of the bioluminescence emission as the single substitution at position Trp86, even with coelenterazine <italic>i</italic>, but, in contrast, they did exhibit greater red-shift in emission wavelength. The variants with non-natural amino acid substitutions at both positions, Tyr82 and Trp86, show a mixed influence of both substitutions, with longer emission half-lives as well as greater red-shifted emission spectra. These emission characteristics may allow for multiplex detection by spatial and temporal resolution through the differentiation of the emission wavelength and time [<xref rid="pone.0158579.ref051" ref-type="bibr">51</xref>].</p><p>The feasibility of employing the red-shifted aequorin variants for <italic>in vivo</italic> imaging was explored by injecting the photoproteins into the right eyes (intrastromal as well as antechamber) of anesthetized mice, chosen for their easy accessibility and simple anatomy as well as for the potential to replace fluorescence in eye studies. The variants with L-4-methoxyphenylalanine at positions 82 and 86 and L-4-iodophenylalanine at positions 82 and 86 were chosen for their red-shifted emission wavelength and long bioluminescence half-life, respectively. The left eyes of the mice were only injected with buffers to serve as internal controls. Additionally, mice without aequorin injected into either eye were imaged. <xref ref-type="fig" rid="pone.0158579.g005">Fig 5</xref> shows the imaging experiments performed by intrastromal injection of identical concentrations of aequorin and L-4-methoxyphenylalanine variants. Native coelenterazine was added to the surface of the eye dropwise to turn &#x0201c;on&#x0201d; the light, that is, trigger the emission of the flash of bioluminescence from the photoproteins, which was immediately recorded by the IVIS. External addition of calcium ions was not necessary since the eye already contains an abundance of calcium ions. <xref ref-type="fig" rid="pone.0158579.g005">Fig 5</xref> also shows bioluminescence emission from the aequorin and the L-4-iodophenylalanine variant injected into the antechamber of the eye. The L-4-iodophenylalanine variant was added at a greater concentration due to the lower specific activity exhibited in the <italic>in vitro</italic> studies (<xref ref-type="supplementary-material" rid="pone.0158579.s004">S2 Table</xref>). The mice were observed for up to 1 1/2 hours after the addition of the coelenterazine and still displayed bioluminescence, attributed to the time necessary for the coelenterazine to diffuse to the aequorin. There was also no bioluminescent signal outside of the eye itself, demonstrating that the aequorin did not diffuse to other areas after injection. These results with <italic>in vivo</italic> imaging suggest that these red-shifted aequorin variants could also be used for imaging studies in other tissues or organs in animals in the future. Bioluminescent resonance energy transfer (BRET) employing aequorin has been demonstrated effective in deep tissue studies, thus suggesting that the aequorin designed, prepared, and employed herein could potentially be translated to applications in deeper tissues [<xref rid="pone.0158579.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0158579.ref064" ref-type="bibr">64</xref>].</p><fig id="pone.0158579.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0158579.g005</object-id><label>Fig 5</label><caption><title>Bioluminescence emission of selected aequorin variants in an <italic>in vivo</italic> mouse model.</title><p>Mice received a 5 &#x003bc;L intrastromal or antechamber injection in the right eye with variant aequorin and the left eye with HEPES Buffer. (A,B) Aequorin injected intrastromally at a concentration of 2.7 x 10<sup>&#x02212;5</sup> M, 30 s exposure. (C) Aequorin with L-4-methoxyphenylalanine at positions 82 and 86. (D) HEPES Buffer only in both eyes. (E) Aequorin injected in the antechamber at a concentration of 3.2 x 10<sup>&#x02212;5</sup> M, 60 s exposure. (F) Aequorin with L-4-iodophenylalanine at positions 82 and 86. Images generated with Matlab R2014b and LivingImage 4.4. Reprinted from [<xref rid="pone.0158579.ref047" ref-type="bibr">47</xref>] under a CC BY license, with permission from <italic>Open Access Dissertations</italic>, original copyright 2015.</p></caption><graphic xlink:href="pone.0158579.g005"/></fig></sec><sec sec-type="conclusions" id="sec003"><title>Conclusions</title><p>In conclusion, our data demonstrate that aequorin variants containing non-natural amino acids in place of the tryptophan residue at position 86 and the tyrosine at position 82 showed red-shifted bioluminescence activity when complexed with native coelenterazine. Moreover, the peak emission wavelengths and half-lives of these variants can further be extended by using coelenterazine analogs. Though not all the mutants showed a significant shift and displayed a drop in specific activity associated with coelenterazine analogs, several had shifts beyond 45 nm and were tested <italic>in vivo</italic>. The aequorin variant with L-4-methoxyphenylalanine at positions 82 and 86 with complexed coelenterazine <italic>i</italic> displays a &#x00394;56 nm red-shift in bioluminescence emission wavelength, being 526 nm the greatest red-shift reported thus far for an aequorin variant. Thus, this broadens the realm of applications of aequorin variants as reporter molecules in multiplex applications and <italic>in vivo</italic> imaging. These red-shifted aequorin variants showed excellent performance in imaging experiments when applied to the eye of a mouse, thus demonstrating their potential use in molecular imaging for diagnostics and/or management of disease. In summary, the red-shifted aequorin variants prepared and reported herein demonstrated improved characteristics for <italic>in vivo</italic> imaging with regard to our previously reported photoproteins, broadening the applications of aequorin in biomedical analysis and diagnostics.</p></sec><sec sec-type="materials|methods" id="sec004"><title>Materials and Methods</title><sec id="sec005"><title>Ethics statement</title><p>All animal procedures were performed in compliance with the Association for Research and Vision in Ophthalmology (ARVO) Statement for the use of Animals in Ophthalmic and Vision Research and in accordance with the Guide for the Care and Use of Laboratory Animals (protocol 13&#x02013;034) published by the National Institutes of Health and approved by the Animal Care and Use Committee of the University of Miami.</p></sec><sec id="sec006"><title>Reagents</title><p>The pBAD/His A and Terrific Broth (TB) are from Invitrogen (Carlsbad, CA). The PET-30 Xa/LIC Kit and Xa Factor Cleavage Capture Kit are from Novagen (Madison, WI). NcoI and HindIII restriction endonucleases are from New England Biolabs (Boston, MA). All natural amino acids, and all antibiotics, are from Sigma-Aldrich (St. Louis, MO). LB agar and LB broth are from Fischer Scientific (Fair Lawn, NJ). The coelenterazines are from Gold Biotechnology (St. Louis, MO). The L-4-aminophenylalanine, L-4-bromophenylalanine, L-4-iodophenylalanine, and L-4-methoxyphenylalanine are from Peptech (Burlington, MA).</p></sec><sec id="sec007"><title>Apparatus</title><p>Cells were grown in a Thermo-Fisher Scientific orbital shaker incubator at 37&#x000b0;C. Cell cultures were harvested using a Beckman J2-MI centrifuge. The proteins were purified using a BioCad Sprint Perfusion Chromatography System (Perseptive Biosystems, Farmington, MA) using 20 mL DEAE Waters AP-2 Anion Exchange Column (Waters Corporation, Milford, MA). The buffers for the purification of the protein were 30 mM Tris-HCl, pH 7.5, containing 2 mM EDTA (Buffer A) and 30 mM Tris-HCl, pH 7.5, containing 2 mM EDTA, and 1 M NaCl (Buffer B). Diafiltration was performed using a tangential flow separation module with hollow fiber filter membrane (Spectrum Labs, Rancho Dominguez, CA) using 30 mM Tris-HCl, pH 7.5, containing 2 mM EDTA. Ni-NTA Agarose beads are from Qiagen (Venlo, Netherlands). Amicon Ultra-15 Centrifugal Filter Units are from EMD (Billerica, MA). Purity of the proteins was confirmed by the appearance of a single band after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using a Novex Mini-cell apparatus from Invitrogen and staining with Coomassie Brilliant Blue. Aequorin activity was measured using an Optocomp I luminometer (MGM Biomedical Hamden, CT). The emission spectra of the aequorins were determined using a custom made SpectroScan instrument (ScienceWares, Falmouth, MA), which is capable of obtaining spectra from flash reactions of luminescent samples that emit in the 400&#x02013;700 nm range. Half-life scans were taken using a Polarstar Optimax 96 well microplate reading luminometer (BMG Labtech, Ortenberg, Germany).</p></sec><sec id="sec008"><title>Construction of the pDULE-pBADHisA-AEQTAG86 expression strains</title><p>Four pDULE vectors which allow for the site-specific incorporation of four different non-natural amino acids were obtained from Dr. Peter Schultz (Scripps Research Institute, La Jolla CA) and Dr. Ryan Mehl (Franklyn and Marshall College, Lancaster, PA) [<xref rid="pone.0158579.ref061" ref-type="bibr">61</xref>]. Each of these pDULE plasmids coded for a tRNA<sub>CUA</sub> and tRNA<sub>CUA</sub>-synthetase specific for the TAG codon and a single non-natural amino acid, either L-4-aminophenylalanine, L-4-bromophenylalanine, L-4-iodophenylalanine, or L-4-methoxyphenylalanine. These plasmids were transformed into <italic>Escherichia coli</italic> DH10B cells and transformants were selected by plating on LB agar medium containing ampicillin (100 &#x003bc;g/mL) and tetracycline (12 &#x003bc;g/mL). The presence of the pDULE plasmid was confirmed by plasmid isolation, restriction enzyme digestion and DNA gel electrophoresis.</p></sec><sec id="sec009"><title>Construction of the pDULE-pET30AEQ8286TAG expression strains</title><p>The four pDULE plasmids were transformed into <italic>E</italic>. <italic>coli</italic> DH10B cells with pET30AEQ8286TAG and transformants were selected by plating on LB agar medium containing tetracycline (12 &#x003bc;g/mL) and kanamycin (35 &#x003bc;g/mL). The presence of the pDULE plasmid was confirmed by plasmid isolation, restriction enzyme digestion and DNA gel electrophoresis.</p><p>pBADAEQ86TAG was prepared by inserting the AEQTAG86 gene with the ompA leader sequence attached into pBAD/HisA. The pIN4AEQ86TAG vector containing the cysteine-free aequorin gene fused to the ompA leader sequence was used as a template. The primers were designed so the resulting DNA sequence contained an NcoI site at the 5&#x02019; end and a HindIII site at the 3&#x02019; end.</p><p>The following primers were used for the cloning of ompA:AEQ86TAG fusion into pBAD/HisA vector (restriction sites for cloning are underlined).</p><sec id="sec010"><title>AEQforpBAD</title><p><monospace>5'-<underline>CCATGG</underline>GTATGAAAAAGACAGCTATCGCGATTGC-3&#x02019;</monospace></p></sec><sec id="sec011"><title>AEQrevpBAD</title><p><monospace>5'<underline>AAGCTT</underline>AGGGGACAGCTCCACCGTAGAGCTTTTCGGAAGCAGGATCCATTGTGTAC-3&#x02019;</monospace></p><p>The resulting PCR product was gel purified and cloned into the pCR<sup>&#x000ae;</sup>II-TOPO<sup>&#x000ae;</sup> vector by using the TOPO TA cloning kit (Invitrogen, Carlsbad, CA). The plasmid from the TA clone was then isolated and sequenced to confirm the presence of the insert. The ompA:AEQ86TAG insert from the TOPO TA clone was then ligated into the NcoI and HindIII sites of pBAD/His A to create pBADHisA-AEQ86TAG.</p><p>The AEQTAG86 gene was also cloned into a pET30 Xa/LIC Vector using primers designed according to the manufacturer&#x02019;s instructions. pET30AEQ8286TAG was then prepared by using a pair of primers to create a site-specific mutation consisting of a TAG at position 82 (underlined).</p></sec><sec id="sec012"><title>Oligo HPLCTAG8286for</title><p><monospace>5'-GGAAACTGATTGGCCTGCA<underline>TAG</underline>ATTGAAGG-3&#x02019;</monospace></p></sec><sec id="sec013"><title>HPLCTAG8286rev</title><p><monospace>5'-CCTTCAAT<underline>CTA</underline>TGCAGGCCAATCAGTTTCC-3&#x02019;</monospace></p><p>pBADHisA-AEQ86TAG and pET30AEQ8286TAG vectors were transformed into chemically competent <italic>E</italic>. <italic>coli</italic> DH10B cells that already contained the pDULE plasmids to produce four different strains, each specific for the incorporation one of the four non-natural amino acids mentioned above. Selection for transformants was performed by plating on LB agar medium containing both ampicillin (100 &#x003bc;g/mL) kanamycin (35 &#x003bc;g/mL) for cells containing pBADHisA-AEQ86TAG and tetracycline (12 &#x003bc;g/mL) and kanamycin (35 &#x003bc;g/mL) for cells containing pET30AEQ8286TAG.</p></sec></sec><sec id="sec014"><title>Expression and isolation of aequorin variants from pBADHisA-AEQ86TAG</title><p>The cells harboring the pDULE systems with pBADHisA-AEQ86TAG vector were grown in 25 mL of LB broth containing ampicillin (100 &#x003bc;g/mL) and tetracycline (12 &#x003bc;g/mL). All cultures, unless specified otherwise, were grown overnight at 37&#x000b0;C with shaking at 250 rpm. These overnight cultures were used to inoculate 500 mL of LB broth containing the appropriate antibiotics and the cultures were grown at 37&#x000b0;C at 250 rpm to an OD<sub>600</sub> between 0.4&#x02013;0.6. The corresponding non-natural amino acid was then added to a final concentration of 1 mM. The culture was allowed to grow for 1 hour and then induced with arabinose (0.2% final concentration) overnight.</p><p>The culture was centrifuged at 15,300 xg for 20 min and the pellet discarded. The supernatant was acid precipitated using 12 M HCl, then spun again. The pellet was resuspended in Tris-HCl, pH 7.5, containing 2 mM EDTA.</p></sec><sec id="sec015"><title>Expression and isolation of aequorin variants from pET30AEQ8286TAG</title><p>The cells were grown in 25 mL of Terrific broth (TB) containing tetracycline (12 &#x003bc;g /mL) and kanamycin (35 &#x003bc;g/mL) overnight at 37&#x000b0;C at 250 rpm. The overnight cultures were used to inoculate 500 mL of TB broth containing the same antibiotics and the cultures were grown at 37&#x000b0;C at 250 rpm. After growing to an OD<sub>600</sub> between 0.4&#x02013;0.6, the corresponding non-natural amino acid was added to a final concentration of 1 mM. The culture was allowed to grow for 1 hour and then induced with 1 mM IPTG and grown overnight.</p><p>The culture was centrifuged at 15,300 xg for 20 min and the pellet was boiled for 5 min in Native Purification Buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, 0.5 M NaCl, 1 mM Imidazole, pH = 8.0). The boiled pellet was centrifuged again and the supernatant added to 1 mL of suspended Ni-NTA agarose beads and rotated on a Mini Labroller (Labnet, Woodridge, NJ) at room temperature for 2 hours. The protein was eluted off the column using a PBS Buffer with 20 mM imidazole at pH = 8.0 and digested with Xa factor according to manufacturer&#x02019;s instructions until all the His tag was cleaved from the protein. The Xa factor was removed with Xa factor Agarose capture beads. The cleaved aequorin was then concentrated using Amicon Ultra spin columns.</p></sec><sec id="sec016"><title>Determination of activities of aequorin variants</title><p>Aequorin was diluted with 30 mM Tris-HCl, pH 7.5, containing 2 mM EDTA, to 1x10<sup>-7</sup> M and charged with 1x10<sup>-4</sup> M coelenterazine overnight. Aequorin activity was triggered by injecting 100 &#x003bc;L of 100 mM Tris-HCl, pH 7.5, containing 100 mM CaCl<sub>2</sub>. Bioluminescence intensity was measured at 0.1 s intervals for up to 6 s on an Optocomp I luminometer (MGM Biomedical Hamden, CT). Units are in Relative Light Units (RLU) per mole. N = 3 or more, standard deviation is 5% or less.</p></sec><sec id="sec017"><title>Emission spectra of aequorin variants</title><p>A 1 x 10<sup>&#x02212;6</sup> M sample of each aequorin was charged by incubating overnight at 4&#x000b0;C with 1x10<sup>-4</sup> M of each of the different coelenterazines and 150 &#x003bc;L of each charged aequorin was pipetted into a 96-well microtiter plate and following injection of 100 &#x003bc;L of 100 mM Tris-HCl, pH 7.5, containing 100 mM CaCl<sub>2</sub>, the emission spectra was collected for 10 s over a scanning range of 400&#x02013;700 nm in 1.5 nm increments on a custom made SpectroScan instrument (ScienceWares, Falmouth, MA). N = 3 or more, standard deviation is 5% or less.</p></sec><sec id="sec018"><title>Half-life determination of aequorin variants</title><p>A 1x10<sup>-6</sup> M sample of each aequorin variant was charged overnight at 4&#x000b0;C with the 1x10<sup>-4</sup> M of the coelenterazine analogue used during the collection of emission spectra. A Polarstar Optimax 96 well microplate luminometer (BMG Labtech, Ortenberg, Germany) was utilized for the half-life measurements. Filters were not required. The bioluminescence signal of a 50 &#x003bc;L sample was collected between 30 s to 150 s, depending on the expected half-life of the aequorin analogue, following the injection of 100 &#x003bc;L of triggering buffer (100 mM Tris-HCl, pH 7.5, containing 100 mM CaCl<sub>2</sub>). The mean bioluminescence decay spectra was fit with an exponential decay equation using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA), and an equation for first order decay kinetics was used to calculate the bioluminescence half-life of each aequorin-coelenterazine pair. N = 3 or more, standard deviation is 5% or less.</p></sec><sec id="sec019"><title>Mass spectrometry</title><p>Proteins were run on SDS-PAGE and cut out of the stained gels with Coomassie Blue. Gel pieces were digested with trypsin, and an LC-ESI-MS-MS was performed using a ThermoFinnigan LTQ. Resulting MS-MS spectra were compared with proteins in the Swiss-Prot database using the X!Tandem search engine to look for the presence of the substitution of the non-natural amino acid at and only at the target positions.</p></sec><sec id="sec020"><title><italic>In vivo</italic> imaging</title><p>The aequorin variants were dissolved in a HEPES Buffer (10 mM HEPES, 0.15 M NaCl at pH = 7.4) at concentrations from 9.1 x 10<sup>&#x02212;6</sup> M to 4.5 x 10<sup>&#x02212;5</sup> M. All mice were anesthetized with a 100 &#x003bc;L ketamine/xylazine (1.5 mg/0.3 mg) by intraperitoneal injection before the injection of the sample. The aequorin samples were injected into one eye of six mice via intrastromal injection in 5 &#x003bc;L volumes, or into the antechamber at a volume of 10 &#x003bc;L, of each of the ICR (CD1) outbred female mice (6&#x02013;8 weeks old, purchased from Taconic (Germantown, NY)). The same volumes of plain HEPES were injected into the other eye to serve as an internal control. Native coelenterazine was diluted in PBS buffer to a volume of 2.3 x 10<sup>&#x02212;4</sup> M and dropped onto the surface of each eye in 1 &#x003bc;L volumes. The mice were then placed in a Caliper/Xenogen IVIS<sup>&#x000ae;</sup> SPECTRUM (Caliper, Hopkinton, MA) in the IVIS Small Animal Imaging Facility at the Oncogenmonics Core Facility, Miller School of Medicine, with oxygen flowing into the imaging chamber. Images were taken over 30 s to 60 s.</p></sec></sec><sec sec-type="supplementary-material" id="sec021"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0158579.s001"><label>S1 Fig</label><caption><title>Plasmids for expression of aequorin variant proteins.</title><p>(A) pBAD-based plasmid inducible by arabinose for the expression of variant aequorin with a singular amber mutation at position 86. (B) pET30-based plasmid inducible by IPTG for the expression of aequorin with an amber mutation at positions 82 and 86 and the sequence encoding for a His6xtag at the N-terminus.</p><p>(DOC)</p></caption><media xlink:href="pone.0158579.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s002"><label>S2 Fig</label><caption><title>SDS Gel Showing Purified Aequorin and Aequorin with L-4-iodophenylalanine at position 82 and 86.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s002.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s003"><label>S1 Table</label><caption><title>Mass spectrometry data for the aequorin mutants.</title><p>(A) Mass spectrometry for a single substitution. Tryptophan 86 is located at the end of the peptide fragment (W*). (B) Mass spectrometry data for a double substitution. Tyrosine 82 is located near the middle of the fragment (Y*).</p><p>(DOC)</p></caption><media xlink:href="pone.0158579.s003.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s004"><label>S2 Table</label><caption><title>Specific activity of aequorin variants: (A) Single substitution at position 86 and (B) Double substitution aequorin variants at positions 82 and 86.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s004.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s005"><label>S3 Table</label><caption><title>Emission wavelengths of aequorin variants.</title><p>(A) Single substitution at position 86 and (B) Double substitutions at 82 and 86 in nm. N = 3 or more, standard deviation is 5% or less.</p><p>(DOC)</p></caption><media xlink:href="pone.0158579.s005.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s006"><label>S4 Table</label><caption><title>Emission half-lives of aequorin variants.</title><p>(A) Single substitution at position 86 and (B) Double substitutions at 82 and 86. The half-life values of the bioluminescence are in s. N = 3 or more, standard deviation is 5% or less.</p><p>(DOC)</p></caption><media xlink:href="pone.0158579.s006.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s007"><label>S5 Table</label><caption><title>Mass Spectrometry Data for AminoPhe86AEQ.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s007.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s008"><label>S6 Table</label><caption><title>Mass Spectrometry Data for BromoPhe86AEQ.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s008.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s009"><label>S7 Table</label><caption><title>Mass Spectrometry Data for IodoPhe86AEQ.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s009.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s010"><label>S8 Table</label><caption><title>Mass Spectrometry Data for MethoxyPhe86AEQ.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s010.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s011"><label>S9 Table</label><caption><title>Mass Spectrometry Data for BromoPhe8286AEQ.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s011.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s012"><label>S10 Table</label><caption><title>Mass Spectrometry Data for IodoPhe8286AEQ.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s012.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0158579.s013"><label>S11 Table</label><caption><title>Mass Spectrometry Data for MethoxyPhe8286AEQ.</title><p>(DOC)</p></caption><media xlink:href="pone.0158579.s013.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>S.D. is grateful for the financial support by the Lucille P. Markey Chair from the Miller School of Medicine of the University of Miami. The authors are grateful to Dr. Peter Schultz of the Scripps Research Institute, La Jolla, CA for generously donating the pDULE plasmid.</p></ack><ref-list><title>References</title><ref id="pone.0158579.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Negrin</surname><given-names>RS</given-names></name>, <name><surname>Contag</surname><given-names>CH</given-names></name>. <article-title>In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease</article-title>. <source>Nature reviews Immunology</source>. <year>2006</year>;<volume>6</volume>(<issue>6</issue>):<fpage>484</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1038/nri1879</pub-id> .<?supplied-pmid 16724101?><pub-id pub-id-type="pmid">16724101</pub-id></mixed-citation></ref><ref id="pone.0158579.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Shinde</surname><given-names>R</given-names></name>, <name><surname>Perkins</surname><given-names>J</given-names></name>, <name><surname>Contag</surname><given-names>CH</given-names></name>. <article-title>Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays</article-title>. <source>Biochemistry</source>. <year>2006</year>;<volume>45</volume>(<issue>37</issue>):<fpage>11103</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1021/bi060475o</pub-id> .<?supplied-pmid 16964971?><pub-id pub-id-type="pmid">16964971</pub-id></mixed-citation></ref><ref id="pone.0158579.ref003"><label>3</label><mixed-citation publication-type="book"><source>Photoproteins in Bioanalysis</source>. <name><surname>Daunert</surname><given-names>S</given-names></name>, <name><surname>Deo</surname><given-names>S</given-names></name>, editors. <publisher-loc>Weinheim, DE</publisher-loc>: <publisher-name>Wiley-VCH</publisher-name>; <year>2006</year>
<fpage>240</fpage> p.</mixed-citation></ref><ref id="pone.0158579.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>De</surname><given-names>A</given-names></name>, <name><surname>Gambhir</surname><given-names>SS</given-names></name>. <article-title>Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer</article-title>. <source>FASEB journal: official publication of the Federation of American Societies for Experimental Biology</source>. <year>2005</year>;<volume>19</volume>(<issue>14</issue>):<fpage>2017</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1096/fj.05-4628fje</pub-id> .<?supplied-pmid 16204354?><pub-id pub-id-type="pmid">16204354</pub-id></mixed-citation></ref><ref id="pone.0158579.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Dothager</surname><given-names>RS</given-names></name>, <name><surname>Flentie</surname><given-names>K</given-names></name>, <name><surname>Moss</surname><given-names>B</given-names></name>, <name><surname>Pan</surname><given-names>MH</given-names></name>, <name><surname>Kesarwala</surname><given-names>A</given-names></name>, <name><surname>Piwnica-Worms</surname><given-names>D</given-names></name>. <article-title>Advances in bioluminescence imaging of live animal models</article-title>. <source>Current opinion in biotechnology</source>. <year>2009</year>;<volume>20</volume>(<issue>1</issue>):<fpage>45</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2009.01.007</pub-id>
<?supplied-pmid 19233638?><pub-id pub-id-type="pmid">19233638</pub-id></mixed-citation></ref><ref id="pone.0158579.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Dragulescu-Andrasi</surname><given-names>A</given-names></name>, <name><surname>Chan</surname><given-names>CT</given-names></name>, <name><surname>De</surname><given-names>A</given-names></name>, <name><surname>Massoud</surname><given-names>TF</given-names></name>, <name><surname>Gambhir</surname><given-names>SS</given-names></name>. <article-title>Bioluminescence resonance energy transfer (BRET) imaging of protein-protein interactions within deep tissues of living subjects</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2011</year>;<volume>108</volume>(<issue>29</issue>):<fpage>12060</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1100923108</pub-id>
<?supplied-pmid 21730157?><pub-id pub-id-type="pmid">21730157</pub-id></mixed-citation></ref><ref id="pone.0158579.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Prescher</surname><given-names>JA</given-names></name>, <name><surname>Contag</surname><given-names>CH</given-names></name>. <article-title>Guided by the light: visualizing biomolecular processes in living animals with bioluminescence</article-title>. <source>Current opinion in chemical biology</source>. <year>2010</year>;<volume>14</volume>(<issue>1</issue>):<fpage>80</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2009.11.001</pub-id> .<?supplied-pmid 19962933?><pub-id pub-id-type="pmid">19962933</pub-id></mixed-citation></ref><ref id="pone.0158579.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>L</given-names></name>, <name><surname>Dikici</surname><given-names>E</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Engineering Bioluminescent Proteins: Expanding their Analytical Potential</article-title>. <source>Anal Chem</source>. <year>2009</year>;<volume>81</volume>(<issue>21</issue>):<fpage>8662</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1021/Ac9007286</pub-id><comment>.</comment> ISI:000276191900007. <?supplied-pmid 19725502?><pub-id pub-id-type="pmid">19725502</pub-id></mixed-citation></ref><ref id="pone.0158579.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>W</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>. <article-title>Nanoplatforms for targeted molecular imaging in living subjects</article-title>. <source>Small</source>. <year>2007</year>;<volume>3</volume>(<issue>11</issue>):<fpage>1840</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/smll.200700351</pub-id> .<?supplied-pmid 17943716?><pub-id pub-id-type="pmid">17943716</pub-id></mixed-citation></ref><ref id="pone.0158579.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Choy</surname><given-names>G</given-names></name>, <name><surname>O'Connor</surname><given-names>S</given-names></name>, <name><surname>Diehn</surname><given-names>FE</given-names></name>, <name><surname>Costouros</surname><given-names>N</given-names></name>, <name><surname>Alexander</surname><given-names>HR</given-names></name>, <name><surname>Choyke</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging</article-title>. <source>BioTechniques</source>. <year>2003</year>;<volume>35</volume>(<issue>5</issue>):<fpage>1022</fpage>&#x02013;<lpage>6</lpage>, <fpage>8</fpage>&#x02013;<lpage>30</lpage>. .<?supplied-pmid 14628676?><pub-id pub-id-type="pmid">14628676</pub-id></mixed-citation></ref><ref id="pone.0158579.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Massoud</surname><given-names>TF</given-names></name>, <name><surname>Gambhir</surname><given-names>SS</given-names></name>. <article-title>Molecular imaging in living subjects: seeing fundamental biological processes in a new light</article-title>. <source>Genes &#x00026; development</source>. <year>2003</year>;<volume>17</volume>(<issue>5</issue>):<fpage>545</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1047403</pub-id> .<?supplied-pmid 12629038?><pub-id pub-id-type="pmid">12629038</pub-id></mixed-citation></ref><ref id="pone.0158579.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>O'Neill</surname><given-names>K</given-names></name>, <name><surname>Lyons</surname><given-names>SK</given-names></name>, <name><surname>Gallagher</surname><given-names>WM</given-names></name>, <name><surname>Curran</surname><given-names>KM</given-names></name>, <name><surname>Byrne</surname><given-names>AT</given-names></name>. <article-title>Bioluminescent imaging: a critical tool in pre-clinical oncology research</article-title>. <source>The Journal of pathology</source>. <year>2010</year>;<volume>220</volume>(<issue>3</issue>):<fpage>317</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1002/path.2656</pub-id> .<?supplied-pmid 19967724?><pub-id pub-id-type="pmid">19967724</pub-id></mixed-citation></ref><ref id="pone.0158579.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Pantaleo</surname><given-names>MA</given-names></name>, <name><surname>Nannini</surname><given-names>M</given-names></name>, <name><surname>Maleddu</surname><given-names>A</given-names></name>, <name><surname>Fanti</surname><given-names>S</given-names></name>, <name><surname>Ambrosini</surname><given-names>V</given-names></name>, <name><surname>Nanni</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy</article-title>. <source>Cancer treatment reviews</source>. <year>2008</year>;<volume>34</volume>(<issue>2</issue>):<fpage>103</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctrv.2007.10.001</pub-id> .<?supplied-pmid 18055120?><pub-id pub-id-type="pmid">18055120</pub-id></mixed-citation></ref><ref id="pone.0158579.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Razgulin</surname><given-names>A</given-names></name>, <name><surname>Ma</surname><given-names>N</given-names></name>, <name><surname>Rao</surname><given-names>J</given-names></name>. <article-title>Strategies for in vivo imaging of enzyme activity: an overview and recent advances</article-title>. <source>Chemical Society reviews</source>. <year>2011</year>;<volume>40</volume>(<issue>7</issue>):<fpage>4186</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1039/c1cs15035a</pub-id> .<?supplied-pmid 21552609?><pub-id pub-id-type="pmid">21552609</pub-id></mixed-citation></ref><ref id="pone.0158579.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Weissleder</surname><given-names>R</given-names></name>, <name><surname>Pittet</surname><given-names>MJ</given-names></name>. <article-title>Imaging in the era of molecular oncology</article-title>. <source>Nature</source>. <year>2008</year>;<volume>452</volume>(<issue>7187</issue>):<fpage>580</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nature06917</pub-id>
<?supplied-pmid 18385732?><pub-id pub-id-type="pmid">18385732</pub-id></mixed-citation></ref><ref id="pone.0158579.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Bhaumik</surname><given-names>S</given-names></name>, <name><surname>Gambhir</surname><given-names>SS</given-names></name>. <article-title>Optical imaging of Renilla luciferase reporter gene expression in living mice</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2002</year>;<volume>99</volume>(<issue>1</issue>):<fpage>377</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.012611099</pub-id>
<?supplied-pmid 11752410?><pub-id pub-id-type="pmid">11752410</pub-id></mixed-citation></ref><ref id="pone.0158579.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Bhaumik</surname><given-names>S</given-names></name>, <name><surname>Lewis</surname><given-names>XZ</given-names></name>, <name><surname>Gambhir</surname><given-names>SS</given-names></name>. <article-title>Optical imaging of Renilla luciferase, synthetic Renilla luciferase, and firefly luciferase reporter gene expression in living mice</article-title>. <source>Journal of biomedical optics</source>. <year>2004</year>;<volume>9</volume>(<issue>3</issue>):<fpage>578</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1117/1.1647546</pub-id> .<?supplied-pmid 15189096?><pub-id pub-id-type="pmid">15189096</pub-id></mixed-citation></ref><ref id="pone.0158579.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>De</surname><given-names>A</given-names></name>, <name><surname>Loening</surname><given-names>AM</given-names></name>, <name><surname>Gambhir</surname><given-names>SS</given-names></name>. <article-title>An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects</article-title>. <source>Cancer research</source>. <year>2007</year>;<volume>67</volume>(<issue>15</issue>):<fpage>7175</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-4623</pub-id> .<?supplied-pmid 17671185?><pub-id pub-id-type="pmid">17671185</pub-id></mixed-citation></ref><ref id="pone.0158579.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Massoud</surname><given-names>TF</given-names></name>, <name><surname>Paulmurugan</surname><given-names>R</given-names></name>, <name><surname>Gambhir</surname><given-names>SS</given-names></name>. <article-title>Molecular imaging of homodimeric protein-protein interactions in living subjects</article-title>. <source>FASEB journal: official publication of the Federation of American Societies for Experimental Biology</source>. <year>2004</year>;<volume>18</volume>(<issue>10</issue>):<fpage>1105</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1096/fj.03-1128fje</pub-id> .<?supplied-pmid 15132989?><pub-id pub-id-type="pmid">15132989</pub-id></mixed-citation></ref><ref id="pone.0158579.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Close</surname><given-names>DM</given-names></name>, <name><surname>Xu</surname><given-names>T</given-names></name>, <name><surname>Sayler</surname><given-names>GS</given-names></name>, <name><surname>Ripp</surname><given-names>S</given-names></name>. <article-title>In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals</article-title>. <source>Sensors</source>. <year>2011</year>;<volume>11</volume>(<issue>1</issue>):<fpage>180</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.3390/s110100180</pub-id>
<?supplied-pmid 22346573?><pub-id pub-id-type="pmid">22346573</pub-id></mixed-citation></ref><ref id="pone.0158579.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Zinn</surname><given-names>KR</given-names></name>, <name><surname>Chaudhuri</surname><given-names>TR</given-names></name>, <name><surname>Szafran</surname><given-names>AA</given-names></name>, <name><surname>O'Quinn</surname><given-names>D</given-names></name>, <name><surname>Weaver</surname><given-names>C</given-names></name>, <name><surname>Dugger</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Noninvasive Bioluminescence Imaging in Small Animals</article-title>. <source>ILAR Journal</source>. <year>2008</year>;<volume>49</volume>(<issue>1</issue>):<fpage>103</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1093/ilar.49.1.103</pub-id>
<?supplied-pmid 18172337?><pub-id pub-id-type="pmid">18172337</pub-id></mixed-citation></ref><ref id="pone.0158579.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Leppanen</surname><given-names>O</given-names></name>, <name><surname>Bjornheden</surname><given-names>T</given-names></name>, <name><surname>Evaldsson</surname><given-names>M</given-names></name>, <name><surname>Boren</surname><given-names>J</given-names></name>, <name><surname>Wiklund</surname><given-names>O</given-names></name>, <name><surname>Levin</surname><given-names>M</given-names></name>. <article-title>ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo</article-title>. <source>Atherosclerosis</source>. <year>2006</year>;<volume>188</volume>(<issue>2</issue>):<fpage>323</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2005.11.017</pub-id> .<?supplied-pmid 16405894?><pub-id pub-id-type="pmid">16405894</pub-id></mixed-citation></ref><ref id="pone.0158579.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>J</given-names></name>, <name><surname>Lin</surname><given-names>AH</given-names></name>, <name><surname>Masliah</surname><given-names>E</given-names></name>, <name><surname>Wyss-Coray</surname><given-names>T</given-names></name>. <article-title>Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2006</year>;<volume>103</volume>(<issue>48</issue>):<fpage>18326</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0605077103</pub-id>
<?supplied-pmid 17110447?><pub-id pub-id-type="pmid">17110447</pub-id></mixed-citation></ref><ref id="pone.0158579.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Curie</surname><given-names>T</given-names></name>, <name><surname>Rogers</surname><given-names>KL</given-names></name>, <name><surname>Colasante</surname><given-names>C</given-names></name>, <name><surname>Brulet</surname><given-names>P</given-names></name>. <article-title>Red-shifted aequorin-based bioluminescent reporters for in vivo imaging of Ca2 signaling</article-title>. <source>Molecular imaging</source>. <year>2007</year>;<volume>6</volume>(<issue>1</issue>):<fpage>30</fpage>&#x02013;<lpage>42</lpage>. .<?supplied-pmid 17311763?><pub-id pub-id-type="pmid">17311763</pub-id></mixed-citation></ref><ref id="pone.0158579.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Johnsn</surname><given-names>FH</given-names></name>, <name><surname>Shimomura</surname><given-names>O</given-names></name>. <article-title>Preparation and use of aequorin for rapid microdetermination of Ca 2+ in biological systems</article-title>. <source>Nature: New biology</source>. <year>1972</year>;<volume>237</volume>(<issue>78</issue>):<fpage>287</fpage>&#x02013;<lpage>8</lpage>. Epub 1972/06/28. .<?supplied-pmid 4402563?><pub-id pub-id-type="pmid">4402563</pub-id></mixed-citation></ref><ref id="pone.0158579.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Shimomura</surname><given-names>O</given-names></name>, <name><surname>Johnson</surname><given-names>FH</given-names></name>, <name><surname>Saiga</surname><given-names>Y</given-names></name>. <article-title>Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea</article-title>. <source>Journal of cellular and comparative physiology</source>. <year>1962</year>;<volume>59</volume>:<fpage>223</fpage>&#x02013;<lpage>39</lpage>. Epub 1962/06/01. .<?supplied-pmid 13911999?><pub-id pub-id-type="pmid">13911999</pub-id></mixed-citation></ref><ref id="pone.0158579.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Ordenes</surname><given-names>VR</given-names></name>, <name><surname>Moreno</surname><given-names>I</given-names></name>, <name><surname>Maturana</surname><given-names>D</given-names></name>, <name><surname>Norambuena</surname><given-names>L</given-names></name>, <name><surname>Trewavas</surname><given-names>AJ</given-names></name>, <name><surname>Orellana</surname><given-names>A</given-names></name>. <article-title>In vivo analysis of the calcium signature in the plant Golgi apparatus reveals unique dynamics</article-title>. <source>Cell calcium</source>. <year>2012</year>;<volume>52</volume>(<issue>5</issue>):<fpage>397</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2012.06.008</pub-id> .<?supplied-pmid 22831913?><pub-id pub-id-type="pmid">22831913</pub-id></mixed-citation></ref><ref id="pone.0158579.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Markova</surname><given-names>O</given-names></name>, <name><surname>Lenne</surname><given-names>PF</given-names></name>. <article-title>Calcium signaling in developing embryos: focus on the regulation of cell shape changes and collective movements</article-title>. <source>Seminars in cell &#x00026; developmental biology</source>. <year>2012</year>;<volume>23</volume>(<issue>3</issue>):<fpage>298</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2012.03.006</pub-id> .<?supplied-pmid 22414534?><pub-id pub-id-type="pmid">22414534</pub-id></mixed-citation></ref><ref id="pone.0158579.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Teasley Hamorsky</surname><given-names>K</given-names></name>, <name><surname>Ensor</surname><given-names>CM</given-names></name>, <name><surname>Wei</surname><given-names>Y</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>A bioluminescent molecular switch for glucose</article-title>. <source>Angew Chem Int Ed Engl</source>. <year>2008</year>;<volume>47</volume>(<issue>20</issue>):<fpage>3718</fpage>&#x02013;<lpage>21</lpage>. Epub 2008/04/03. <pub-id pub-id-type="doi">10.1002/anie.200704440</pub-id> .<?supplied-pmid 18383457?><pub-id pub-id-type="pmid">18383457</pub-id></mixed-citation></ref><ref id="pone.0158579.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Teasley Hamorsky</surname><given-names>K</given-names></name>, <name><surname>Ensor</surname><given-names>CM</given-names></name>, <name><surname>Dikici</surname><given-names>E</given-names></name>, <name><surname>Pasini</surname><given-names>P</given-names></name>, <name><surname>Bachas</surname><given-names>L</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenyls</article-title>. <source>Anal Chem</source>. <year>2012</year>;<volume>84</volume>(<issue>18</issue>):<fpage>7648</fpage>&#x02013;<lpage>55</lpage>. Epub 2012/08/23. <pub-id pub-id-type="doi">10.1021/ac301872u</pub-id> .<?supplied-pmid 22908962?><pub-id pub-id-type="pmid">22908962</pub-id></mixed-citation></ref><ref id="pone.0158579.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Scott</surname><given-names>D</given-names></name>, <name><surname>Hamorsky</surname><given-names>KT</given-names></name>, <name><surname>Ensor</surname><given-names>CM</given-names></name>, <name><surname>Anderson</surname><given-names>KW</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Cyclic AMP receptor protein-aequorin molecular switch for cyclic AMP</article-title>. <source>Bioconjugate chemistry</source>. <year>2011</year>;<volume>22</volume>(<issue>3</issue>):<fpage>475</fpage>&#x02013;<lpage>81</lpage>. Epub 2011/02/19. <pub-id pub-id-type="doi">10.1021/bc100486b</pub-id>
<?supplied-pmid 21329338?><pub-id pub-id-type="pmid">21329338</pub-id></mixed-citation></ref><ref id="pone.0158579.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Hamorsky</surname><given-names>KT</given-names></name>, <name><surname>Ensor</surname><given-names>CM</given-names></name>, <name><surname>Pasini</surname><given-names>P</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>A protein switch sensing system for the quantification of sulfate</article-title>. <source>Analytical biochemistry</source>. <year>2012</year>;<volume>421</volume>(<issue>1</issue>):<fpage>172</fpage>&#x02013;<lpage>80</lpage>. Epub 2011/11/10. <pub-id pub-id-type="doi">10.1016/j.ab.2011.10.023</pub-id>
<?supplied-pmid 22067979?><pub-id pub-id-type="pmid">22067979</pub-id></mixed-citation></ref><ref id="pone.0158579.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Zenno</surname><given-names>S</given-names></name>, <name><surname>Inouye</surname><given-names>S</given-names></name>. <article-title>Bioluminescent immunoassay using a fusion protein of protein A and the photoprotein aequorin</article-title>. <source>Biochemical and biophysical research communications</source>. <year>1990</year>;<volume>171</volume>(<issue>1</issue>):<fpage>169</fpage>&#x02013;<lpage>74</lpage>. Epub 1990/08/31. .<?supplied-pmid 2203343?><pub-id pub-id-type="pmid">2203343</pub-id></mixed-citation></ref><ref id="pone.0158579.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Qu</surname><given-names>X</given-names></name>, <name><surname>Deo</surname><given-names>SK</given-names></name>, <name><surname>Dikici</surname><given-names>E</given-names></name>, <name><surname>Ensor</surname><given-names>M</given-names></name>, <name><surname>Poon</surname><given-names>M</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Bioluminescence immunoassay for angiotensin II using aequorin as a label</article-title>. <source>Analytical biochemistry</source>. <year>2007</year>;<volume>371</volume>(<issue>2</issue>):<fpage>154</fpage>&#x02013;<lpage>61</lpage>. Epub 2007/10/13. <pub-id pub-id-type="doi">10.1016/j.ab.2007.08.038</pub-id> .<?supplied-pmid 17931588?><pub-id pub-id-type="pmid">17931588</pub-id></mixed-citation></ref><ref id="pone.0158579.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Mirasoli</surname><given-names>M</given-names></name>, <name><surname>Deo</surname><given-names>SK</given-names></name>, <name><surname>Lewis</surname><given-names>JC</given-names></name>, <name><surname>Roda</surname><given-names>A</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Bioluminescence immunoassay for cortisol using recombinant aequorin as a label</article-title>. <source>Analytical biochemistry</source>. <year>2002</year>;<volume>306</volume>(<issue>2</issue>):<fpage>204</fpage>&#x02013;<lpage>11</lpage>. Epub 2002/07/19. .<?supplied-pmid 12123657?><pub-id pub-id-type="pmid">12123657</pub-id></mixed-citation></ref><ref id="pone.0158579.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>JC</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Bioluminescence immunoassay for thyroxine employing genetically engineered mutant aequorins containing unique cysteine residues</article-title>. <source>Anal Chem</source>. <year>2001</year>;<volume>73</volume>(<issue>14</issue>):<fpage>3227</fpage>&#x02013;<lpage>33</lpage>. Epub 2001/07/31. .<?supplied-pmid 11476219?><pub-id pub-id-type="pmid">11476219</pub-id></mixed-citation></ref><ref id="pone.0158579.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Desai</surname><given-names>UA</given-names></name>, <name><surname>Wininger</surname><given-names>JA</given-names></name>, <name><surname>Lewis</surname><given-names>JC</given-names></name>, <name><surname>Ramanathan</surname><given-names>S</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Using epitope-aequorin conjugate recognition in immunoassays for complex proteins</article-title>. <source>Analytical biochemistry</source>. <year>2001</year>;<volume>294</volume>(<issue>2</issue>):<fpage>132</fpage>&#x02013;<lpage>40</lpage>. Epub 2001/07/11. <pub-id pub-id-type="doi">10.1006/abio.2001.5145</pub-id> .<?supplied-pmid 11444808?><pub-id pub-id-type="pmid">11444808</pub-id></mixed-citation></ref><ref id="pone.0158579.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Deo</surname><given-names>SK</given-names></name>, <name><surname>Lewis</surname><given-names>JC</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>C-terminal and n-terminal fusions of aequorin with small peptides in immunoassay development</article-title>. <source>Bioconjugate chemistry</source>. <year>2001</year>;<volume>12</volume>(<issue>3</issue>):<fpage>378</fpage>&#x02013;<lpage>84</lpage>. Epub 2001/05/17. .<?supplied-pmid 11353535?><pub-id pub-id-type="pmid">11353535</pub-id></mixed-citation></ref><ref id="pone.0158579.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Deo</surname><given-names>SK</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>An immunoassay for Leu-enkephalin based on a C-terminal aequorin-peptide fusion</article-title>. <source>Anal Chem</source>. <year>2001</year>;<volume>73</volume>(<issue>8</issue>):<fpage>1903</fpage>&#x02013;<lpage>8</lpage>. Epub 2001/05/08. .<?supplied-pmid 11338609?><pub-id pub-id-type="pmid">11338609</pub-id></mixed-citation></ref><ref id="pone.0158579.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>L</given-names></name>, <name><surname>Deo</surname><given-names>S</given-names></name>, <name><surname>Shofner</surname><given-names>J</given-names></name>, <name><surname>Ensor</surname><given-names>M</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Aequorin-based homogeneous cortisol immunoassay for analysis of saliva samples</article-title>. <source>Bioconjugate chemistry</source>. <year>2007</year>;<volume>18</volume>(<issue>6</issue>):<fpage>1772</fpage>&#x02013;<lpage>7</lpage>. Epub 2007/10/19. <pub-id pub-id-type="doi">10.1021/bc070039u</pub-id> .<?supplied-pmid 17941683?><pub-id pub-id-type="pmid">17941683</pub-id></mixed-citation></ref><ref id="pone.0158579.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Shrestha</surname><given-names>S</given-names></name>, <name><surname>Paeng</surname><given-names>IR</given-names></name>, <name><surname>Deo</surname><given-names>SK</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Cysteine-free mutant of aequorin as a photolabel in immunoassay development</article-title>. <source>Bioconjugate chemistry</source>. <year>2002</year>;<volume>13</volume>(<issue>2</issue>):<fpage>269</fpage>&#x02013;<lpage>75</lpage>. Epub 2002/03/22. .<?supplied-pmid 11906264?><pub-id pub-id-type="pmid">11906264</pub-id></mixed-citation></ref><ref id="pone.0158579.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Inouye</surname><given-names>S</given-names></name>, <name><surname>Noguchi</surname><given-names>M</given-names></name>, <name><surname>Sakaki</surname><given-names>Y</given-names></name>, <name><surname>Takagi</surname><given-names>Y</given-names></name>, <name><surname>Miyata</surname><given-names>T</given-names></name>, <name><surname>Iwanaga</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Cloning and sequence analysis of cDNA for the luminescent protein aequorin</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>1985</year>;<volume>82</volume>(<issue>10</issue>):<fpage>3154</fpage>&#x02013;<lpage>8</lpage>. Epub 1985/05/01. <?supplied-pmid 3858813?><pub-id pub-id-type="pmid">3858813</pub-id></mixed-citation></ref><ref id="pone.0158579.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Head</surname><given-names>JF</given-names></name>, <name><surname>Inouye</surname><given-names>S</given-names></name>, <name><surname>Teranishi</surname><given-names>K</given-names></name>, <name><surname>Shimomura</surname><given-names>O</given-names></name>. <article-title>The crystal structure of the photoprotein aequorin at 2.3 A resolution</article-title>. <source>Nature</source>. <year>2000</year>;<volume>405</volume>(<issue>6784</issue>):<fpage>372</fpage>&#x02013;<lpage>6</lpage>. Epub 2000/06/01. <pub-id pub-id-type="doi">10.1038/35012659</pub-id> .<?supplied-pmid 10830969?><pub-id pub-id-type="pmid">10830969</pub-id></mixed-citation></ref><ref id="pone.0158579.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Eremeeva</surname><given-names>EV</given-names></name>, <name><surname>Markova</surname><given-names>SV</given-names></name>, <name><surname>Westphal</surname><given-names>AH</given-names></name>, <name><surname>Visser</surname><given-names>AJWG</given-names></name>, <name><surname>van Berkel</surname><given-names>WJH</given-names></name>, <name><surname>Vysotski</surname><given-names>ES</given-names></name>. <article-title>The intrinsic fluorescence of apo-obelin and apo-aequorin and use of its quenching to characterize coelenterazine binding</article-title>. <source>Febs Lett</source>. <year>2009</year>;<volume>583</volume>(<issue>12</issue>):<fpage>1939</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2009.04.043</pub-id><comment>.</comment> ISI:000267797800020. <?supplied-pmid 19426732?><pub-id pub-id-type="pmid">19426732</pub-id></mixed-citation></ref><ref id="pone.0158579.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Shimomura</surname><given-names>O</given-names></name>, <name><surname>Musicki</surname><given-names>B</given-names></name>, <name><surname>Kishi</surname><given-names>Y</given-names></name>. <article-title>Semi-synthetic aequorin. An improved tool for the measurement of calcium ion concentration</article-title>. <source>The Biochemical journal</source>. <year>1988</year>;<volume>251</volume>(<issue>2</issue>):<fpage>405</fpage>&#x02013;<lpage>10</lpage>. Epub 1988/04/15. <?supplied-pmid 3401214?><pub-id pub-id-type="pmid">3401214</pub-id></mixed-citation></ref><ref id="pone.0158579.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>L</given-names></name>, <name><surname>Ensor</surname><given-names>M</given-names></name>, <name><surname>Mehl</surname><given-names>R</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Modulating the Bioluminescence Emission of Photoproteins by in Vivo Site-Directed Incorporation of Non-Natural Amino Acids</article-title>. <source>Acs Chem Biol</source>. <year>2010</year>;<volume>5</volume>(<issue>5</issue>):<fpage>455</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1021/Cb9002909</pub-id><comment>.</comment> ISI:000277865500004. <?supplied-pmid 20230005?><pub-id pub-id-type="pmid">20230005</pub-id></mixed-citation></ref><ref id="pone.0158579.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Grinstead</surname><given-names>KM</given-names></name>. <article-title>Aequorin Mutants with Site-Specifically Incorporated Non-Natural Amino Acids for Biomedical Applications</article-title>. <source>Open Access Journals: University of Miami</source>; <year>2015</year>.</mixed-citation></ref><ref id="pone.0158579.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>JC</given-names></name>, <name><surname>Lopez-Moya</surname><given-names>JJ</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Bioluminescence and secondary structure properties of aequorin mutants produced for site-specific conjugation and immobilization</article-title>. <source>Bioconjugate chemistry</source>. <year>2000</year>;<volume>11</volume>(<issue>1</issue>):<fpage>65</fpage>&#x02013;<lpage>70</lpage>. Epub 2000/01/19. .<?supplied-pmid 10639087?><pub-id pub-id-type="pmid">10639087</pub-id></mixed-citation></ref><ref id="pone.0158579.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Tsuzuki</surname><given-names>K</given-names></name>, <name><surname>Tricoire</surname><given-names>L</given-names></name>, <name><surname>Courjean</surname><given-names>O</given-names></name>, <name><surname>Gibelin</surname><given-names>N</given-names></name>, <name><surname>Rossier</surname><given-names>J</given-names></name>, <name><surname>Lambolez</surname><given-names>B</given-names></name>. <article-title>Thermostable mutants of the photoprotein aequorin obtained by in vitro evolution</article-title>. <source>J Biol Chem</source>. <year>2005</year>;<volume>280</volume>(<issue>40</issue>):<fpage>34324</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M505303200</pub-id><comment>.</comment> ISI:000232229700075. <?supplied-pmid 15972815?><pub-id pub-id-type="pmid">15972815</pub-id></mixed-citation></ref><ref id="pone.0158579.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Tricoire</surname><given-names>L</given-names></name>, <name><surname>Tsuzuki</surname><given-names>K.</given-names></name>, <name><surname>Courjean</surname><given-names>O.</given-names></name>, <etal>et al</etal>
<article-title>Calcium Dependence of Aequorin Bioluminescnece Dissected by Random Mutagenesis</article-title>. <source>cPNAS</source>. <year>2006</year>;<volume>103</volume>(<issue>25</issue>):<fpage>5</fpage>.</mixed-citation></ref><ref id="pone.0158579.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>L</given-names></name>, <name><surname>Combs</surname><given-names>K</given-names></name>, <name><surname>Deo</surname><given-names>S</given-names></name>, <name><surname>Ensor</surname><given-names>C</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>, <name><surname>Qu</surname><given-names>X</given-names></name>. <article-title>Genetically modified semisynthetic bioluminescent photoprotein variants: simultaneous dual-analyte assay in a single well employing time resolution of decay kinetics</article-title>. <source>Anal Chem</source>. <year>2008</year>;<volume>80</volume>(<issue>22</issue>):<fpage>8470</fpage>&#x02013;<lpage>6</lpage>. Epub 2008/10/22. <pub-id pub-id-type="doi">10.1021/ac801209x</pub-id> .<?supplied-pmid 18937418?><pub-id pub-id-type="pmid">18937418</pub-id></mixed-citation></ref><ref id="pone.0158579.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Dikici</surname><given-names>E</given-names></name>, <name><surname>Qu</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Aequorin variants with improved bioluminescence properties</article-title>. <source>Protein engineering, design &#x00026; selection: PEDS</source>. <year>2009</year>;<volume>22</volume>(<issue>4</issue>):<fpage>243</fpage>&#x02013;<lpage>8</lpage>. Epub 2009/01/27. <pub-id pub-id-type="doi">10.1093/protein/gzn083</pub-id>
<?supplied-pmid 19168563?><pub-id pub-id-type="pmid">19168563</pub-id></mixed-citation></ref><ref id="pone.0158579.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Scott</surname><given-names>D</given-names></name>, <name><surname>Dikici</surname><given-names>E</given-names></name>, <name><surname>Ensor</surname><given-names>M</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Bioluminescence and its impact on bioanalysis</article-title>. <source>Annu Rev Anal Chem (Palo Alto Calif)</source>. <year>2011</year>;<volume>4</volume>:<fpage>297</fpage>&#x02013;<lpage>319</lpage>. Epub 2011/04/05. <pub-id pub-id-type="doi">10.1146/annurev-anchem-061010-113855</pub-id> .<?supplied-pmid 21456969?><pub-id pub-id-type="pmid">21456969</pub-id></mixed-citation></ref><ref id="pone.0158579.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Qu</surname><given-names>X</given-names></name>, <name><surname>Rowe</surname><given-names>L</given-names></name>, <name><surname>Dikici</surname><given-names>E</given-names></name>, <name><surname>Ensor</surname><given-names>M</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Aequorin mutants with increased thermostability</article-title>. <source>Analytical and bioanalytical chemistry</source>. <year>2014</year>;<volume>406</volume>(<issue>23</issue>):<fpage>5639</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-014-8039-6</pub-id>
<?supplied-pmid 25084737?><pub-id pub-id-type="pmid">25084737</pub-id></mixed-citation></ref><ref id="pone.0158579.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Dikici</surname><given-names>E</given-names></name>, <name><surname>Qu</surname><given-names>X</given-names></name>, <name><surname>Rowe</surname><given-names>L</given-names></name>, <name><surname>Millner</surname><given-names>L</given-names></name>, <name><surname>Logue</surname><given-names>C</given-names></name>, <name><surname>Deo</surname><given-names>SK</given-names></name>, <etal>et al</etal>
<article-title>Aequorin variants with improved bioluminescence properties</article-title>. <source>Protein engineering, design &#x00026; selection: PEDS</source>. <year>2009</year>;<volume>22</volume>(<issue>4</issue>):<fpage>243</fpage>&#x02013;<lpage>8</lpage>. Epub 2009/01/27. <pub-id pub-id-type="doi">10.1093/protein/gzn083</pub-id>
<?supplied-pmid 19168563?><pub-id pub-id-type="pmid">19168563</pub-id></mixed-citation></ref><ref id="pone.0158579.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Lark</surname><given-names>AR</given-names></name>, <name><surname>Kitamoto</surname><given-names>T</given-names></name>, <name><surname>Martin</surname><given-names>JR</given-names></name>. <article-title>In Vivo Functional Brain Imaging Approach Based on Bioluminescent Calcium Indicator GFP-aequorin</article-title>. <source>J Vis Exp</source>. <year>2016</year>;(<issue>107</issue>). <pub-id pub-id-type="doi">10.3791/53705</pub-id> .<?supplied-pmid 26779599?><pub-id pub-id-type="pmid">26779599</pub-id></mixed-citation></ref><ref id="pone.0158579.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>JC</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Photoproteins as luminescent labels in binding assays</article-title>. <source>Fresen J Anal Chem</source>. <year>2000</year>;<volume>366</volume>(<issue>6&#x02013;7</issue>):<fpage>760</fpage>&#x02013;<lpage>8</lpage>. ISI:000086661300025.</mixed-citation></ref><ref id="pone.0158579.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>L</given-names></name>, <name><surname>Rothert</surname><given-names>A</given-names></name>, <name><surname>Logue</surname><given-names>C</given-names></name>, <name><surname>Ensor</surname><given-names>CM</given-names></name>, <name><surname>Deo</surname><given-names>SK</given-names></name>, <name><surname>Daunert</surname><given-names>S</given-names></name>. <article-title>Spectral tuning of photoproteins by partnering site-directed mutagenesis strategies with the incorporation of chromophore analogs</article-title>. <source>Protein engineering, design &#x00026; selection: PEDS</source>. <year>2008</year>;<volume>21</volume>(<issue>2</issue>):<fpage>73</fpage>&#x02013;<lpage>81</lpage>. Epub 2008/01/08. <pub-id pub-id-type="doi">10.1093/protein/gzm073</pub-id> .<?supplied-pmid 18175778?><pub-id pub-id-type="pmid">18175778</pub-id></mixed-citation></ref><ref id="pone.0158579.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Chatterjee</surname><given-names>A</given-names></name>, <name><surname>Xiao</surname><given-names>H</given-names></name>, <name><surname>Schultz</surname><given-names>PG</given-names></name>. <article-title>Evolution of multiple, mutually orthogonal prolyl-tRNA synthetase/tRNA pairs for unnatural amino acid mutagenesis in Escherichia coli</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2012</year>;<volume>109</volume>(<issue>37</issue>):<fpage>14841</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1212454109</pub-id>
<?supplied-pmid 22927411?><pub-id pub-id-type="pmid">22927411</pub-id></mixed-citation></ref><ref id="pone.0158579.ref060"><label>60</label><mixed-citation publication-type="book"><name><surname>Maniatis</surname><given-names>T</given-names></name>, <name><surname>Fritsch</surname><given-names>EF</given-names></name>, <name><surname>Sambrook</surname><given-names>J</given-names></name>. <source>Molecular cloning: a laboratory manual</source>. <publisher-loc>Cold Spring Harbor, N.Y.</publisher-loc>: <publisher-name>Cold Spring Harbor Laboratory</publisher-name>; <year>1982</year>
<volume>x</volume>, <fpage>545</fpage> p. p.</mixed-citation></ref><ref id="pone.0158579.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>CC</given-names></name>, <name><surname>Schultz</surname><given-names>PG</given-names></name>. <article-title>Adding new chemistries to the genetic code</article-title>. <source>Annual review of biochemistry</source>. <year>2010</year>;<volume>79</volume>:<fpage>413</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.052308.105824</pub-id> .<?supplied-pmid 20307192?><pub-id pub-id-type="pmid">20307192</pub-id></mixed-citation></ref><ref id="pone.0158579.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Nijegorodov</surname><given-names>N</given-names></name>, <name><surname>Mabbs</surname><given-names>R</given-names></name>. <article-title>The influence of molecular symmetry and topological factors on the internal heavy atom effect in aromatic and heteroaromatic compounds</article-title>. <source>Spectrochimica acta Part A, Molecular and biomolecular spectroscopy</source>. <year>2001</year>;<volume>57</volume>(<issue>7</issue>):<fpage>1449</fpage>&#x02013;<lpage>62</lpage>. Epub 2001/07/12. .<?supplied-pmid 11446700?><pub-id pub-id-type="pmid">11446700</pub-id></mixed-citation></ref><ref id="pone.0158579.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Bakayan</surname><given-names>A</given-names></name>, <name><surname>Domingo</surname><given-names>B</given-names></name>, <name><surname>Miyawaki</surname><given-names>A</given-names></name>, <name><surname>Llopis</surname><given-names>J</given-names></name>. <article-title>Imaging Ca activity in mammalian cells and zebrafish with a novel red-emitting aequorin variant</article-title>. <source>Pflugers Archiv: European journal of physiology</source>. <year>2014</year>
<pub-id pub-id-type="doi">10.1007/s00424-014-1639-3</pub-id> .<?supplied-pmid 25355614?><pub-id pub-id-type="pmid">25355614</pub-id></mixed-citation></ref><ref id="pone.0158579.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Bakayan</surname><given-names>A</given-names></name>, <name><surname>Vaquero</surname><given-names>CF</given-names></name>, <name><surname>Picazo</surname><given-names>F</given-names></name>, <name><surname>Llopis</surname><given-names>J</given-names></name>. <article-title>Red fluorescent protein-aequorin fusions as improved bioluminescent Ca2+ reporters in single cells and mice</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e19520</fpage> Epub 2011/05/19. <pub-id pub-id-type="doi">10.1371/journal.pone.0019520</pub-id>
<?supplied-pmid 21589654?><pub-id pub-id-type="pmid">21589654</pub-id></mixed-citation></ref></ref-list></back></article>